
Andrew J. Storaska
How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline
Biosimilars Law Bulletin ·
Immunex Loses Battle Over Institution of Follow-on IPR Petitions
Biosimilars Law Bulletin ·
AbbVie Loses Battle to Drop Royalties on Blockbuster Humira®
Biosimilars Law Bulletin ·
Update: How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline
Biosimilars Law Bulletin ·